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one year after PD initiation. No peritonitis
episodes were detected in the following
years.
In 2009, he came to hospital with mild ab-
dominal pain with four hours of evolution.
He hadn’t other symptoms, exit-site had-
n’t inflammatory signs and effluent was
clear. Effluent analysis revealed 26
cells/µl (table 1), abdominal radiography
and ultrasound were normal.
Intraperitoneal vancomycin (2 g each
5 days) and ceftazidime (1 g each day)
were administrated and patient was disca-
rried, maintaining icodextrin.
In the next day, he returned with cloudy
effluent (table 1). The same treatment was
maintained and cloudy effluent disappea-
red in the two following days.
At the 5th day, he was asymptomatic and
came for second vancomycin administra-
tion. Latter in that day, abdominal pain
and cloudy effluent reappeared (table 1).
PD was suspended and hemodialysis was
started. Vancomycin and ceftazidime were
switch to intravenous route and an extra
daily dose of intraperitoneal ceftazidime
(500 mg) was maintained. He became as-
ymptomatic and cloudy effluent disappe-
ared in the following two days. All cultu-
res, including fungus and Mycobacterium
tuberculosis were sterile.
At the 9th day, he reassumed PD (with
icodextrin) and at 10th day intraperito-
neal vancomycin was delivered. Cloudy
effluent reappeared after vancomycin ad-
ministration. At 12th day, he was as-
ymptomatic and discarried (table 1).
Three months later, he remains asympto-
matic, with preserved ultrafiltration and
clean effluent.
Patients with peritonitis usually present
with cloudy fluid and abdominal pain. Ef-
fluent’s leukocytes superior to 100/ml
(with 50% polymophonuclear cells) indi-
cate the presence of inflammation, with
infectious peritonitis being the most likely
cause3. However, in short dwell time leu-
kocytes may not reach 100/ml3 and peri-
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To the Editor, 
Peritonitis is the principal cause of perito-
neal dialysis (PD) catheter loss and the
primary reason why patients switch from
PD to hemodialysis1. It causes death in 6%
of patients, particularly when it is caused
by Staphylococcus aureus, enteric orga-
nisms and fungus2.
Prompt initiation of antibiotics is critical
and they should be started as soon as a
cloudy effluent is seen, even without con-
firmation of the cell count from labora-
tory3. Guidelines recommend empirical
treatment with an association of vancomy-
cin or a cephalosporin with aminoglycosi-
de or third-generation cephalosporin3.
Chemical peritonitis, described as perito-
neal inflammation caused by a non-infec-
tious agent (such antibiotics and dialysis
solutions) is a rarer condition.
Chemical peritonitis induced by van-
comycin was first described in 19864 and
near 90 similar cases were reported in the
80-90th decade5,6. Since then no other
case was noted.
Icodextrin-induced peritonitis has first
described in 19997, but its prevalence is
not clear. An epidemic outbreak occurred
in Europe in 2002, related to solution con-
tamination8. Few cases were reported af-
ter improving manufacturing process, all
related to “sensibilization” during that pe-
riod or to other contaminations8.
We reported a case of chemical peritonitis
in a patient treated with icodextrin and in-
traperitoneal vancomycin, in which van-
comycin seems to be the offending agent.
A 34-year-old man, with renal failure se-
condary to diabetic nephropathy, was in
PD since 2006. Icodextrin was introduced
tonitis may present with abdominal pain
and no cloudy effluent3.
In our patient, other causes of abdominal
pain such as gastroenteritis, pancreatitis,
appendicitis or pneumoperitoneum were
excluded and empirical treatment for in-
fectious peritonitis was started. The
cloudy effluent present in the following
day was assumed to be a late expression
of peritonitis in fluid of a longer dwell
time.
Abdominal pain and cloudy effluent re-
appeared after second vancomycin admi-
nistration and he was admitted with sus-
picion of refractory peritonitis. If the
suspicion was confirmed, peritoneal ca-
theter should be removed and patient
switched to hemodialysis9. However, he
didn’t present the typical evolution of a
refractory infectious peritonitis and other
causes of cloudy effluent, such as hemo-
peritoneum, malignancy, eosinophilic
and chylous effluent were excluded10.
Chemical peritonitis related to icodextrin
or vancomycin remained a plausible
diagnosis5,6.
Icodextrin induced-peritonitis seems to be
caused by contamination of solution by
peptidoglycans released from bacteria
(Alicylobacillus acidocaldarius) during
the manufacturing process8. Improvement
in the process decreased its frequency
from a peak of 0.912% in 2002 to 0.013%
in 20038.
Patients present with mild abdominal
pain and cloudy effluent, without re-
bound, fever or rash11,12. Effluent leu-
kocytes vary from 100 to 6,000/µl11,13,
with mononuclear predominance11. Cul-
ture is always sterile11.
Delay between the initiation of the ico-
dextrin and first symptoms varies from
few hours to several years7,12. Clinical
course is undulating, with intermittent
pain and dialysate cloudiness after each
icodextrin dwell, without response to
antibiotics12. Discontinuation of icodex-
trin leads to relief of the symptoms and
normalization of leukocytes within 24-
48 hours, but relapse is invariably indu-
ced after rechallenge12.
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No fatalities were reported6,7 and no treat-
ment is recommended except for suspen-
sion of offending agent7.
Although it is clinically benign with
spontaneous resolution, the long-term
sequelae are still unknown. Moreover,
it could be confused with infectious pe-
ritonitis and lead to unnecessary anti-
biotic prescription or to catheter remo-
val and PD suspension7.
In last 15 years, none case of vancomycin-
induced peritonitis was reported, maybe
due to progressive improvement in purifi-
cations. In a time where generic prepara-
tions are in increasing use, our case may
alert physicians to the presence of this for-
gotten adverse effect.
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Table 1. Evolution of effluent characteristics
Day 0 Day 1 Day 5 Day 10 Day 12
Pancreatic amylase (U/l) 3 3 3 – –
DHL (U/l) 29 59 22 – –
Erythrocytes (cel/µl) 10 0 10 60 2
Leukocytes (cel/µl) 26 340 3000 7162 163
Neutrophils (cel/µl) 0 238 2250 5819 31
Eosinophils (cel/µl) 0 0 0 0 0
Basophils (cel/µl) 0 0 0 149 0
Monocyts (cel/µl) 26 102 450 1044 87
Limphocyts (cel/µl) – – – 298 45
Macrophages (cel/µl) – – – 0 47
Mesotelial cells (cel/µl) 10 – – – –
Effluent culture Sterile – Sterile Sterile –
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